Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development.
Artificial neural networks (ANN) methodology is a new modeling method that has not been broadly applied to pharmaceutical sciences up to now. The aim of this paper is to give a detailed description of the associating networks as well as a description of less well-known networks (i.e., feature-extracting and nonadaptive networks) and their scope of application in pharmaceutical sciences. The descriptions include the historical origin and the basic concepts behind the computing. ANN are based on the attempt to model the neural networks of the brain. Learning algorithms for associating ANN use mathematical procedures usually derived from the gradient descent method whereas feature-extracting ANN map multidimensional input data sets onto two-dimensional spaces. Nonadaptive ANN map data sets and are able to reconstruct their patterns when presented with corrupted or noisy samples. Associating networks can typically be applied in the pharmaceutical field as an alternative to traditional response surface methodology, feature-extracting networks as alternative to principal component analysis, and nonadaptive networks for image recognition. Based on these abilities, the potential application fields of the ANN methodology in the pharmaceutical sciences is broad, ranging from clinical pharmacy through biopharmacy, drug and dosage form design, to interpretation of analytical data. The few applications presented in the pharmaceutical technology area seem promising and should be investigated in more detail.